Deciphering the progression and regulation of human translesion DNA synthesis
Deciphering the progression and regulation of human translesion DNA synthesis
批准号:
10669748
负责人:
Mark Hedglin
金额:
$39.43万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-05-31
关键词:
AcuteAreaBiochemistryBiologicalBiophysicsCancer EtiologyCell DeathCell SurvivalCellsChromosomal RearrangementClosure by clampCodeComplexCritical PathwaysDNA DamageDNA RepairDNA Replication DamageDNA Replication FactorDNA biosynthesisDNA-Directed DNA PolymeraseDiseaseEnvironmentEventExposure toFibroblast Growth FactorFunctional disorderGeneticGenomeGoalsHealthHumanHuman ActivitiesHuman GenomeKineticsKnowledgeLinkMalignant NeoplasmsModificationMolecularMolecular BiologyMonoubiquitinationMutagenesisPathway interactionsPropertyRegulationResearchResearch ProposalsSiteSlideTechniquescancer cellcancer therapycarcinogenesischemotherapydesignhuman DNA damageinterestprogramsrecruit
中文摘要
项目总结/摘要
我的研究计划的首要目标是了解人类基因组是如何忠实地
当它被共价修饰不断破坏时,它会复制,从而改变其编码特性。重点
是跨损伤DNA合成(TLS),主要的DNA损伤耐受性(DDT)的途径,利用在
复制受损的DNA TLS利用专门的DNA聚合酶,
一系列的DNA损伤,虽然降低的结晶度,并促进细胞存活,在面对DNA损伤,
使受损基因组的复制得以继续然而,严格的监管是至关重要的,因为异常的TLS可以
选择性地繁殖具有增加的诱变和染色体重排的细胞,这可以导致
癌此外,由于TLS在暴露于DNA损伤剂后促进细胞存活,因此异常的细胞毒性可能是由细胞毒性引起的。
TLS还可以使癌细胞能够克服旨在引发细胞死亡的普通化疗
通过严重破坏DNA因此,TLS是靶向癌症联合治疗的有希望的候选者。尽管
尽管人类健康与TLS之间的联系已经建立,但TLS的进展和调控尚不清楚,许多
关键的差距仍然存在于我们的基础知识中,这些知识使我们对TLS的贡献的理解变得模糊,
遗传和致癌作用。例如,人类滴滴涕至少可以通过三种途径产生,
TLS和其他DDT途径之间的相互作用是什么?我长期以来的兴趣和丰富的专业知识,
人类DNA损伤修复和复制以及我建立的利用多方面方法的能力
整合分子生物学、生物化学和生物物理学为填补这些空白提供了独特的机会。这
提案将通过解决两个广泛的领域来解决TLS的发展和监管问题,
我们对TLS和DDT的基本理解的基石; 1)TLS的激活; 2)
滴滴涕途径之间的相互作用。为此,我们设计并应用独特的定量方法,
动力学技术,可以适应许多生物场景。
PCNA滑动夹是一种重要的DNA复制因子,在DNA复制位点被单倍半胱氨酸化,
Rad6(Rad18)2复合体的破坏。PCNA单泛素化对于人TLS是必要的,并激活
通过招募TLS因子来实现这一关键途径。第一区将研究人类的活动
Rad6(Rad18)2复合物被调节以在DNA损伤位点有效地单泛素化PCNA,
TLS。人体DDT至少可以通过三种途径发生,包括TLS,所有途径都来自一个共同的
中间体区域2将研究TLS和其他DDT途径之间的相互作用,
每个通路中关键事件之间的功能关系。该提案在广泛的背景下研究TLS
它考虑了细胞环境的复杂性和动态性,并将大大推进我们的研究。
基本了解人类基因组如何在DNA损伤面前忠实地复制,
激发了癌症病因学和治疗研究的新途径。
英文摘要
Project Summary/Abstract
The overarching goal of my research program is to understand how the human genome is faithfully
replicated when it is constantly damaged by covalent modifications that can alter its coding properties. A focus
is on translesion DNA synthesis (TLS), the predominant DNA damage tolerance (DDT) pathway utilized in
humans to replicate damaged DNA. TLS utilizes specialized DNA polymerases that can accommodate an
array of DNA damages, albeit with lowered fidelities, and promotes cell survival in the face of DNA damage by
allowing replication of a damaged genome to continue. However, tight regulation is critical as aberrant TLS can
selectively propagate cells with increased mutagenesis and chromosomal rearrangements, which can lead to
cancer. Furthermore, because TLS promotes cell survival after exposure to DNA damaging agents, aberrant
TLS can also afford cancer cells the ability to overcome common chemotherapies that aim to trigger cell death
by acutely damaging DNA. Hence, TLS is a promising candidate for targeted cancer co-therapy. Despite the
established links between human health and TLS, the progression and regulation of TLS is unclear and many
key gaps persist in our fundamental knowledge that cloud our understanding of the contribution of TLS to
genetic inheritance and carcinogenesis. For example, human DDT can occur by at least three pathways but
what is the interplay between TLS and other DDT pathways? My long-standing interests and vast expertise in
human DNA damage repair and replication and my established ability to utilize a multi-faceted approach
integrating molecular biology, biochemistry, and biophysics provide a unique opportunity to fill these gaps. This
proposal will address the progression and regulation of TLS by tackling two broad areas that are each a
cornerstone of our fundamental understanding of TLS and DDT in general; 1) Activation of TLS and; 2) The
interplay between DDT pathways. To do so, we design and apply unique, quantitative approaches that utilize
kinetic techniques and can be adapted to many biological scenarios.
The PCNA sliding clamp is an essential DNA replication factor and is monoubiquitinated at sites of DNA
damage by the Rad6(Rad18)2 complex. PCNA monoubiquitination is imperative for human TLS and activates
this critical pathway by recruiting TLS factors. Area 1 will investigate how the activity of the human
Rad6(Rad18)2 complex is regulated to efficiently monoubiquitinate PCNA at DNA damage sites, activating
TLS. Human DDT can occur by at least three pathways including TLS and all emanate from a common
intermediate. Area 2 will investigate the interplay between TLS and other DDT pathways and decipher
functional relationships between key events in each pathway. This proposal investigates TLS in broad contexts
that consider the complexities and dynamics of cellular environments and will significantly advance our
fundamental understanding of how the human genome is faithfully replicated in the face of DNA damage and
inspire new avenues of research in cancer etiology and treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polymerase Switching During Translesion DNA Synthesis within the Human System
-
批准号:8254525
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2012
-
负责人:Mark Hedglin
-
依托单位:
Polymerase Switching During Translesion DNA Synthesis within the Human System
-
批准号:8529191
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2012
-
负责人:Mark Hedglin
-
依托单位:
Polymerase Switching During Translesion DNA Synthesis within the Human System
-
批准号:8716697
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2012
-
负责人:Mark Hedglin
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: